Imane Abidli is a third-year PhD candidate in Pharmaceutical Sciences at the University of Mons (UMons) and the Université libre de Bruxelles (ULB), supervised by Prof. Francis Vanderbist, Prof. Karim Amighi and Prof. Nathalie Wauthoz. Her doctoral research focuses on the development of an inhaled dry powder combining N-acetylcysteine with quercetin- and lutein-loaded solid lipid nanoparticles, designed as a nano-in-micro "Trojan particle" strategy to disrupt Pseudomonas aeruginosa biofilms in chronic respiratory infections, contributing to the fight against antimicrobial resistance.
Prior to her PhD, she worked as a Research Intern in the Pharmaceutical Analysis Laboratory at UMons (2021–2023), developing and validating UPLC methods with UV and mass spectrometry detection. She graduated with Great Distinction from her Master in Pharmaceutical Sciences, ranking first in her class and receiving the Best Master's Thesis Prize.
Her research interests include nano-in-micro pulmonary drug delivery, spray-dried particle engineering, aerodynamic performance testing, and antibiofilm strategies against antimicrobial resistance. She is a 2024 Laureate of the Van den Put Fund and has presented her work at the European Cystic Fibrosis Conference (Milan, 2025) and the BSPS meeting (La-Roche-en-Ardenne, 2025).
